Bridgeway Capital Management, LLC Biomea Fusion, Inc. Transaction History
Bridgeway Capital Management, LLC
- $3.98 Billion
- Q2 2025
A detailed history of Bridgeway Capital Management, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 70,300 shares of BMEA stock, worth $115,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,300
Previous 35,300
99.15%
Holding current value
$115,995
Previous $75,000
68.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BMEA
# of Institutions
99Shares Held
23.2MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$6.33 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.89 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.87 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$3.38 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.1 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $48.3M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...